Refractory Autoimmune Hemolytic Anemia and Pure Red Cell Aplasia Secondary to Immunotherapy Requiring Prolonged Immunosuppression
JCO Oncol Pract
.
2020 Oct;16(10):699-700.
doi: 10.1200/OP.20.00047.
Epub 2020 Jun 30.
Authors
Mathew Hall
1
,
Nicholas Meti
1
,
Larissa Liontos
1
2
,
Matthew C Cheung
1
2
,
Sonal Gandhi
1
2
Affiliations
1
University of Toronto, Toronto, Ontario, Canada.
2
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
PMID:
32603256
DOI:
10.1200/OP.20.00047
No abstract available
MeSH terms
Anemia, Hemolytic, Autoimmune* / therapy
Humans
Immunologic Factors
Immunosuppression Therapy / adverse effects
Immunotherapy
Red-Cell Aplasia, Pure* / chemically induced
Red-Cell Aplasia, Pure* / therapy
Substances
Immunologic Factors